DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 213 filers reported holding DENALI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,339,401 | -33.4% | 113,398 | -4.7% | 0.00% | -50.0% |
| Q2 2023 | $3,510,185 | +32.3% | 118,949 | +3.3% | 0.00% | +100.0% |
| Q1 2023 | $2,653,816 | -15.5% | 115,183 | +2.8% | 0.00% | -50.0% |
| Q4 2022 | $3,139,462 | -4.4% | 112,059 | +1.6% | 0.00% | 0.0% |
| Q3 2022 | $3,285,120 | -6.2% | 110,257 | -8.3% | 0.00% | 0.0% |
| Q2 2022 | $3,504,102 | -8.2% | 120,287 | +1.9% | 0.00% | -33.3% |
| Q1 2022 | $3,817,166 | +83.0% | 118,085 | +154.0% | 0.00% | +200.0% |
| Q4 2021 | $2,086,000 | -11.9% | 46,496 | -0.9% | 0.00% | -50.0% |
| Q3 2021 | $2,368,000 | -41.2% | 46,935 | -8.6% | 0.00% | -33.3% |
| Q2 2021 | $4,027,000 | +95.7% | 51,333 | +42.4% | 0.00% | +50.0% |
| Q1 2021 | $2,058,000 | -35.8% | 36,046 | -5.8% | 0.00% | -33.3% |
| Q4 2020 | $3,205,000 | +140.8% | 38,264 | +3.0% | 0.00% | +200.0% |
| Q3 2020 | $1,331,000 | +47.1% | 37,147 | -2.8% | 0.00% | 0.0% |
| Q2 2020 | $905,000 | +54.4% | 38,198 | +14.1% | 0.00% | 0.0% |
| Q1 2020 | $586,000 | +10.6% | 33,471 | +9.9% | 0.00% | 0.0% |
| Q4 2019 | $530,000 | +6.9% | 30,444 | -2.7% | 0.00% | 0.0% |
| Q3 2019 | $496,000 | -23.7% | 31,283 | -0.1% | 0.00% | 0.0% |
| Q2 2019 | $650,000 | -10.0% | 31,327 | +0.8% | 0.00% | 0.0% |
| Q1 2019 | $722,000 | +24.3% | 31,078 | +10.6% | 0.00% | 0.0% |
| Q4 2018 | $581,000 | -14.2% | 28,101 | -9.8% | 0.00% | 0.0% |
| Q3 2018 | $677,000 | +184.5% | 31,143 | +99.1% | 0.00% | – |
| Q2 2018 | $238,000 | -16.5% | 15,644 | +8.2% | 0.00% | – |
| Q1 2018 | $285,000 | – | 14,465 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
| Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
| Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
| Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
| SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
| Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
| GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
| BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |